The promotion of arrhythmias in myocytes by mesenchymal stromal cells isolated from failing human hearts, which were found to produce high levels of interleukin-6 (IL-6), was abated in the presence of anti-IL-6 monoclonal antibodies.
Time to telemedicine diagnosis was found to be a useful parameter in assessing the effectiveness of telemedicine in patients who have experienced myocardial infarction.
The estimation of myocardial flow reserve using positron emission tomography may help identify patients with ischemic heart failure who would have improved outcomes with early coronary artery bypass grafting vs percutaneous coronary intervention.
Aboriginal and Torres Strait Islander status may predict death in individuals with acute coronary syndrome.
The Food and Drug Administration approved the 50cc temporary Total Artificial Heart System developed and manufactured by SynCardia Systems, LLC as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.
Multisociety Lifelong Learning Statement focuses on learning competencies necessary for advanced heart failure and transplant cardiology specialists.
Patients with cardiovascular disease diagnosed with novel coronavirus (COVID-19) are urged to continue taking their angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blocker (ARB) medications as prescribed.
Cardiac magnetic resonance imaging demonstrated moderate-good agreement with measurement of fractional flow reserve in evaluating nonculprit lesions after ST-segment elevation myocardial infarction in reperfused patients with multivessel coronary artery disease.
Management of patients with a recently implanted left ventricular assist device necessitates a thorough understanding of the postimplant period and of common critical care issues that may arise from the operating room to critical care discharge.
The use of an intravascular microaxial left ventricular assist device was found to be associated with increased risks for in-hospital mortality and bleeding compared with the use of an intra-aortic balloon pump during percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock.